Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE987B01026 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Natco Pharma L Natco Pharma Ltd. | BSE 918.95 51.45 (5.93%) | NSE 917.55 50.05 (5.77%) | Trade | Add

BSE Live

Dec 11, 16:01

918.95 51.45 (5.93%)

Volume

AVERAGE VOLUME

5-Day

83,363

10-Day

208,919

30-Day

165,533

338,464

Prev. Close

867.50
Open Price

870.05

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 11, 15:57

917.55 50.05 (5.77%)

Volume

AVERAGE VOLUME

5-Day

1,114,122

10-Day

2,909,109

30-Day

2,247,288

6,400,043

Prev. Close

867.50
Open Price

870.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
917.55 (8268)

Financials

Print/Copy to Excel : Go

Balance Sheet of Natco Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	35.80	35.80	36.50	36.50	36.50
Total Share Capital	35.80	35.80	36.50	36.50	36.50
Reserves and Surplus	7,571.20	5,817.30	4,837.30	4,223.70	4,067.60
Total Reserves and Surplus	7,571.20	5,817.30	4,837.30	4,223.70	4,067.60
Total Shareholders Funds	7,607.00	5,853.10	4,873.80	4,263.60	4,121.60
Minority Interest	5.30	0.00	0.00	0.00	1.80
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liabilities [Net]	0.20	0.20	12.40	30.10	41.30
Other Long Term Liabilities	9.20	9.30	2.80	9.30	2.00
Long Term Provisions	65.60	70.90	85.30	95.70	99.60
Total Non-Current Liabilities	75.00	80.40	100.50	135.10	142.90
CURRENT LIABILITIES
Short Term Borrowings	273.10	363.20	165.00	404.00	265.80
Trade Payables	274.90	235.50	263.80	161.80	146.20
Other Current Liabilities	317.60	271.20	237.40	127.60	100.80
Short Term Provisions	77.90	102.90	16.90	17.00	12.80
Total Current Liabilities	943.50	972.80	683.10	710.40	525.60
Total Capital And Liabilities	8,630.80	6,906.30	5,657.40	5,109.10	4,791.90
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2,431.90	2,297.70	2,239.10	2,178.90	2,013.80
Intangible Assets	208.70	137.10	132.60	82.20	9.40
Capital Work-In-Progress	225.40	137.30	64.30	129.50	223.40
Fixed Assets	2,866.00	2,572.10	2,436.00	2,390.60	2,246.60
Non-Current Investments	152.80	95.90	87.30	104.40	159.40
Deferred Tax Assets [Net]	50.10	19.40	0.00	0.00	0.00
Long Term Loans And Advances	0.00	0.00	0.00	0.00	15.80
Other Non-Current Assets	234.50	139.40	78.60	66.20	32.80
Total Non-Current Assets	3,360.80	2,882.80	2,657.10	2,611.90	2,454.60
CURRENT ASSETS
Current Investments	320.80	443.50	305.00	203.70	144.30
Inventories	765.80	700.50	742.90	762.00	798.20
Trade Receivables	1,246.60	1,188.90	856.10	620.60	412.90
Cash And Cash Equivalents	2,176.00	952.90	546.30	206.10	283.50
Short Term Loans And Advances	9.40	9.00	10.20	10.40	13.10
OtherCurrentAssets	751.40	728.70	539.80	694.40	685.30
Total Current Assets	5,270.00	4,023.50	3,000.30	2,497.20	2,337.30
Total Assets	8,630.80	6,906.30	5,657.40	5,109.10	4,791.90
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	50.70	58.80	22.10	22.40	28.00
BONUS DETAILS
Bonus Equity Share Capital	5.62	5.62	5.73	5.73	5.73
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.00	0.00	0.00	39.90	71.20
Non-Current Investments Unquoted Book Value	152.80	95.90	87.30	64.20	89.00
CURRENT INVESTMENTS
Current Investments Quoted Market Value	216.60	109.40	98.90	81.20	15.60
Current Investments Unquoted Book Value	104.20	299.80	204.40	122.10	128.70